Search Within

Martin Stuart Tallman

Formats
  1. Journal Article (320)
  2. Meeting Abstract (278)
  3. Review (19)
  4. Editorial (9)
  5. Book Section (8)
  6. Research Letter (8)
  7. Guidelines (6)
  8. Correspondence (1)
Groups
  1. Adult Leukemia (649)
  2. Center for Hematologic Malignancies (649)
  3. Department of Medicine (649)
  4. Hematologic Malignancies, Division of (649)
  5. GSK Faculty (164)
  6. Executive Committee, Center for Hematologic Malignancies (156)

More Groups

People
  1. Ross Levine (131)
  2. Eytan Stein (114)
  3. Jae Park (79)
  4. Omar Abdel-Wahab (68)
  5. Sean Devlin (65)
  6. Dan Douer (50)

More People

Years
  1. 2025 (3)
  2. 2024 (7)
  3. 2023 (10)
  4. 2022 (26)
  5. 2021 (45)
  6. 2020 (51)

More Years

Publications
  1. Blood (272)
  2. Journal of Clinical Oncology (41)
  3. Leukemia Research (27)
  4. Blood Advances (26)
  5. Leukemia and Lymphoma (26)
  6. Haematologica (24)

More Publications

Publishers
  1. American Society of Hematology (298)
  2. Elsevier Inc. (43)
  3. American Society of Clinical Oncology (41)
  4. Nature Publishing Group (38)
  5. Taylor & Francis Group (28)
  6. Elsevier Ltd (27)

More Publishers

Results (649)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
    Journal Article

    Gu, Z.; Churchman, M. L.; Roberts, K. G.; Moore, I.; Zhou, X.; Nakitandwe, J.; Hagiwara, K.; Pelletier, S.; Gingras, S.; Berns, H.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • LeukeMYC prognostication
    Editorial

    Knorr, K. L. B.; Tallman, M. S.
    Leukemia and Lymphoma (2019)

    Fulltext@MSK | Save
  • Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib
    Journal Article

    Stein, E. M.; DiNardo, C. D.; Fathi, A. T.; Pollyea, D. A.; Stone, R. M.; Altman, J. K.; Roboz, G. J.; Patel, M. R.; Collins, R.; Flinn, I. W.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ECOG-ACRIN study (S0106 and E1900)
    Journal Article

    Medeiros, B. C.; Othus, M.; Tallman, M. S.; Sun, Z.; Fernandez, H. F.; Rowe, J. M.; Lazarus, H. M.; Appelbaum, F. R.; Luger, S. M.; Litzow, M. R.; more...
    Leukemia Research (2019)

    Fulltext@MSK | Save
  • A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease
    Journal Article

    Litzow, M. R.; Wang, X. V.; Carroll, M. P.; Karp, J. E.; Ketterling, R. P.; Zhang, Y.; Kaufmann, S. H.; Lazarus, H. M.; Luger, S. M.; Paietta, E. M.; more...
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • Ivosidenib (IVO; AG-120) in mutant IDH1 relapsed/refractory acute myeloid leukemia (R/R AML): Results of a phase 1 study
    Meeting Abstract

    Pollyea, D. A.; Dinardo, C. D.; de Botton, S.; Stein, E.; Roboz, G. J.; Mims, A. S.; Swords, R. T.; Altman, J. K.; Collins, R.; Mannis, G. N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • First-line therapy for acute promyelocytic leukemia: Chemotherapy-based approach
    Book Section

    Goldberg, A. D.; Tallman, M. S.
    In Abla, O.; Lo Coco, F.; Sanz, M. A. (Eds.) Acute Promyelocytic Leukemia: A Clinical Guide (2018)

    Fulltext@MSK | Save
  • Evolution of a chemosensitive core-binding factor AML into an aggressive leukemia with eosinophilic differentiation
    Journal Article

    Xiao, W.; Yabe, M.; Offin, M.; Khattar, P.; Baik, J.; Daley, R. J.; Pappacena, J. J.; Roshal, M.; Zhang, Y.; Tallman, M. S.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • PHF6 mutations are mutually exclusive to TP53 mutations, and define a distinct subgroup of secondary acute myeloid leukemia associated with a primitive stem/progenitor immunophenotype, absent complex karyotype and relatively better outcomes
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Ball, B.; Famulare, C.; Pastore, F.; Tallman, M. S.; Zhang, Y.; Arcila, M. E.; Papaemmanuil, E.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save